Short answer
Quest Diagnostics (DGX) filed an 8-K current report with the SEC on April 21, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q1 2026 results for quarter ended March 31, 2026.
Quest Diagnostics 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 results for quarter ended March 31, 2026
- Press release issued April 21, 2026
- Detailed financial results and management commentary in Exhibit 99.1
Item EX-99.1 · Exhibit EX-99.1
- Q1 revenue $2.895B, up 9.2%, with organic growth 9.0% and requisition volume up 10.9%
- Reported diluted EPS $2.24, up 15.5%; adjusted EPS $2.50, up 13.1%
- Operating margin expanded to 13.8% from 13.0%; adjusted margin reached 15.4%
- Full-year revenue guidance raised to $11.78B-$11.90B from $11.70B-$11.82B
- Full-year reported EPS raised to $9.58-$9.78 and adjusted EPS to $10.63-$10.83
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Quest Diagnostics 8-K filings
Get the next DGX 8-K as it lands
Follow DGX for push alerts, or ask the research agent what this filing means.